Immunoglobulin heavy chain isotype switch recombination is a regulated recombination event that occurs in antigen-activated B cells. Switch recombination joins the variable region of an expressed heavy chain gene to a constant region of a new class or isotype, deleting the DNA between. Since each of the different classes of constant region removes antigen in a specialized way, the result of switch recombination is to alter the antigen clearance properties of an immunoglobulin molecule without affecting its specificity for antigen, thereby increasing the efficiency of the immune response. The critical importance of switching is evidenced by the fact that certain immunodeficiency diseases are characterized by an inability to carry out switch recombination. The proposed research win study the molecular mechanism of isotype switch recombination.
The aims are: (1) to clone a cDNA that encodes LR1, an inducible factor that we have identified as a candidate regulator of isotype switching, and to characterize expression and function of the LRl DNA binding protein; (2) to study how LRl activity is regulated in response to cell activation; (3) to study the activation and targeting of switch recombination, using extrachromosomal substrates carrying switch region sequences in a sensitive transient recombination assay. Results from these experiments should provide important insights into the mechanism of a process that is central to the human immune response. The mechanism of this regulated and targeted recombination process may also prove relevant to certain of the deletion and recombination events that give rise to genetic disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM039799-07
Application #
2180043
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1988-04-01
Project End
1997-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
7
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Yale University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Yabuki, Munehisa; Cummings, W Jason; Leppard, John B et al. (2012) Antibody discovery ex vivo accelerated by the LacO/LacI regulatory network. PLoS One 7:e36032
Yabuki, Munehisa; Ordinario, Ellen C; Cummings, W Jason et al. (2009) E2A acts in cis in G1 phase of cell cycle to promote Ig gene diversification. J Immunol 182:408-15
Ordinario, Ellen C; Yabuki, Munehisa; Larson, Ryan P et al. (2009) Temporal regulation of Ig gene diversification revealed by single-cell imaging. J Immunol 183:4545-53
Vallur, Aarthy C; Maizels, Nancy (2008) Activities of human exonuclease 1 that promote cleavage of transcribed immunoglobulin switch regions. Proc Natl Acad Sci U S A 105:16508-12
Vallur, A C; Yabuki, M; Larson, E D et al. (2007) AID in antibody perfection. Cell Mol Life Sci 64:555-65
Maizels, Nancy (2006) Dynamic roles for G4 DNA in the biology of eukaryotic cells. Nat Struct Mol Biol 13:1055-9
Maizels, Nancy (2005) Immunoglobulin gene diversification. Annu Rev Genet 39:23-46
Larson, Erik D; Duquette, Michelle L; Cummings, W Jason et al. (2005) MutSalpha binds to and promotes synapsis of transcriptionally activated immunoglobulin switch regions. Curr Biol 15:470-4
Larson, Erik D; Cummings, W Jason; Bednarski, David W et al. (2005) MRE11/RAD50 cleaves DNA in the AID/UNG-dependent pathway of immunoglobulin gene diversification. Mol Cell 20:367-75
Yabuki, Munehisa; Fujii, Monica M; Maizels, Nancy (2005) The MRE11-RAD50-NBS1 complex accelerates somatic hypermutation and gene conversion of immunoglobulin variable regions. Nat Immunol 6:730-6

Showing the most recent 10 out of 38 publications